Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Siona Eliyahu"'
Autor:
Steven A. Rosenberg, Ettore Appella, G J Adema, Paul F. Robbins, Kazuyasu Sakaguchi, Cynthia H. Delgado, John R. Yannelli, Siona Eliyahu, Yutaka Kawakami, Toru Miki
Publikováno v:
Proceedings of the National Academy of Sciences. 91:6458-6462
The cultured T-cell line TIL1200, established from the tumor-infiltrating lymphocytes (TILs) of a patient with advanced metastatic melanoma, recognized an antigen on most HLA-A2+ melanomas and on all HLA-A2+ cultured neonatal melanocytes in an HLA-A2
Autor:
Yutaka Kawakami, Ettore Appella, John R. Yannelli, Siona Eliyahu, Paul F. Robbins, Steven A. Rosenberg, Licia Rivoltini, Kazuyasu Sakaguchi
Publikováno v:
The Journal of Experimental Medicine
Four melanoma proteins, MART-1, gp100, tyrosinase, and tyrosinase-related protein-1 (gp75) were evaluated for recognition by HLA-A2-restricted melanoma-specific cytotoxic T lymphocytes (CTLs) derived from the tumor-infiltrating lymphocytes (TIL) of 1
Autor:
Uzi Gafter, Yona Kalechman, Ian J. Cohen, Benny Motro, Michael Albeck, David Givol, Harry M. Lander, Rivka Gal, Jean-Eudes Dazard, Siona Eliyahu, Benjamin Sredni
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 18(2)
The synthetic immunomodulator AS101[ammonium trichloro(dioxoethylene-o,o')tellurate] was previously found to protect cancer patients from chemotherapy-induced bone marrow toxicity and alopecia. Here we show that AS101 induces hair growth in nude and
Autor:
Daniel Eliyahu, Steve Evans, Soonmyoung Paik, Siona Eliyahu, James A. Zwiebel, Neal Rosen, Marc E. Lippman
Publikováno v:
Breast cancer research and treatment. 30(2)
One common step in the malignant progression of a wide variety of human cancers seems to be inactivation of the p53 gene, via point mutation or deletion or both; or overexpression of mutated protein with dominant transforming activity. This study sho
Publikováno v:
The Journal of Immunology. 178:S78-S78
The Ras family is the most widely mutated group of human proto-oncogene. Previously, we found an organic Tellurium compound, AS101, which exhibits immunomodulatory activity and strong anti-tumor effects. Whether these properties can be exploited for